Abstract
As well-known powerful mucosal adjuvant proteins, Escherichia coli heat-labile enterotoxin (LT) and its non-toxic or low-toxic mutants (LTm) are capable of promoting strong mucosal immune responses to co-administered antigens in various types of vaccines. However, due to the complex composition and special structure, the yield of LTm directly from the recombinant genetic engineering strains is quite low. Here, we put forward a novel method to prepare LTm protein which designed, expressed, and purified three kinds of component subunits respectively and assembled them into a hexamer structure in vitro by two combination modes. In addition, by simulated in vivo environment of polymer protein assembly, the factors of the protein solution system which include environment temperature, pH, ionic strength of the solution, and ratio between each subunit were taken into consideration. Finally, we confirmed the optimal conditions of two assembly strategies and prepared the hexamer holotoxin in vitro. These results are not only an important significance in promoting large-scale preparation of the mucosal adjuvant LTm but also an enlightening to produce other multi-subunit proteins.
References
Aug 1, 1979·Infection and Immunity·S L Kunkel, D C Robertson
Jan 1, 1994·Microbial Pathogenesis·Y UesakaY Takeda
Jan 3, 1994·FEBS Letters·E A MerrittW G Hol
Dec 1, 1996·Journal of Biomolecular NMR·R A LaskowskiJ M Thornton
Jan 1, 1997·Advances in Biophysics·T Takahashi
Oct 26, 1999·Immunology Today·R RappuoliG Dougan
Jul 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·D M Huang, D Chandler
Jul 27, 2002·Journal of Biotechnology·Christian SchliekerAxel Mogk
Nov 6, 2004·Nature Biotechnology·François Baneyx, Mirna Mujacic
Jan 7, 2005·Applied Microbiology and Biotechnology·S Jana, J K Deb
Mar 8, 2005·The Journal of Dairy Research·Stéphanie Bordenave-JuchereauFrédéric Sannier
May 27, 2006·Bioelectrochemistry·Tibor HianikIgor Grman
Sep 13, 2006·FEMS Immunology and Medical Microbiology·Melissa Ang Simões LasaroLuís Carlos de Souza Ferreira
Oct 3, 2006·Biotechnology and Bioengineering·Andrea VeraAntonio Villaverde
Jun 9, 2009·Biotechnology Advances·Arnold L Demain, Preeti Vaishnav
Nov 7, 2009·Methods in Enzymology·William H Brondyk
Dec 18, 2010·Vaccine·Vanusa P da HoraDenise L Doolan
Feb 4, 2011·Clinical and Vaccine Immunology : CVI·Elizabeth B NortonJohn D Clements
Jul 22, 2011·Nature·F Ulrich HartlManajit Hayer-Hartl
Oct 3, 2012·Advanced Drug Delivery Reviews·Xiaoying ChenWei-Chiang Shen
Feb 27, 2013·Infection and Immunity·Louise Sjökvist OttsjöSukanya Raghavan
Jul 31, 2013·The Protein Journal·Gopal Jee Gopal, Awanish Kumar
Sep 21, 2013·Clinical and Vaccine Immunology : CVI·Samer S El-KamaryWilbur H Chen
Jun 28, 2014·Biomolecules·Hiroshi Yamaguchi, Masaya Miyazaki